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IntroductIon
Differentiation of naive CD4 T cells into specialized T helper 
(Th) lymphocyte subsets is crucial to immune responses 
(O’Shea and Paul, 2010). Among Th subsets, T follicular 
helper cells (Tfh) have been characterized for their role in 
B cell help (Tangye et al., 2013). Tfh cells express specific 
sets of secreted and surface molecules, comprising IL-21, 
CXCL13, ICOS, PD1, and CXCR5, which provide import-
ant signals for B cell survival and maturation in the germinal 
centers (GCs; Kim et al., 2004; Crotty, 2014).
The Th1-inducing cytokine IL-12 promotes human 
Tfh polarization (Trinchieri, 2003; Schmitt et al., 2009). Mu-
tations in the IL-12Rb downstream pathway affect IL-21 
production and Tfh generation in humans (Ma et al., 2012). 
IL-27, another Th1-inducing factor, can induce human Tfh 
polarization (Gringhuis et al., 2014). The cytokine cocktail 
used to polarize in vitro human Th17 cells, and in particular 
TGF-β, can promote Tfh development as well (Schmitt et 
al., 2014). Altogether, these data led to the hypothesis that in 
humans Tfh polarization is preferentially associated with Th1 
and Th17 polarizing environments (Ueno et al., 2015).
Tfh cells have been described in Th2-dominated en-
vironments, such as allergy (Kemeny, 2012), and in the ab-
sence of  Th1 and Th17 polarization (Glatman Zaretsky et 
al., 2009; Liang et al., 2011; Tangye et al., 2013). However, 
IL-4, the master Th2 cytokine, inhibits human Tfh differen-
tiation (Schmitt et al., 2014). This raises the important ques-
tion of how Tfh differentiation can occur in Th2-dominated 
environments in humans.
We hypothesized that the epithelial-derived cytokine 
thymic stromal lymphopoietin (TSLP) might play a role in 
Tfh cell polarization. Independent evidences make TSLP a 
strong candidate for Tfh polarization. First, TSLP is highly 
expressed in different Th2-dominated environments, such 
as airways of asthmatic patients, mucosal tissues in helminth 
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infections, and AD lesional skin (Soumelis et al., 2002; Ying 
et al., 2005; Ziegler and Artis, 2010). Both AD and allergic 
patients present deregulated IgE production (Gould et al., 
2003). Second, TSLP is expressed in human tonsils, where 
GC reactions occur (Liu et al., 2007). Third, TSLP contrib-
utes to Th2 polarization through DC activation, and induces 
an inflammatory Th2 response (Soumelis et al., 2002). Fourth, 
TSLP-activated DCs express OX40 ligand (OX40L), which 
has been linked to Tfh polarization (Jacquemin et al., 2015).
In this work, we establish a novel Tfh differentiation 
pathway driven by TSLP. We dissect an axis linking TSLP, 
DCs, T cells, B cells, and IgE production.
rESuLtS
tSLP-activated dcs polarize naive cd4 t cells 
into IL-21–secreting cells
We used primary DCs from human blood activated with 
TSLP (TSLP-DC) to differentiate naive CD4 cells into 
Th cells in an allogeneic system. As expected, after 6 d of 
co-culture, TSLP-DC induced Th cells that secreted IL-4 and 
IL-13, but low levels of IFN-γ, which are features of Th2 
polarization (Fig. 1 A; Soumelis et al., 2002; Ziegler and Artis, 
2010). To separate the effect of TSLP-induced activation from 
an intrinsic property of human blood DCs, we used nonacti-
vated DCs as a negative control. As an additional control, we 
used LPS-activated DCs (LPS-DC), which induced IFN-γ 
but low IL-4 and IL-13 secretion from T cells (Fig. 1 A), in 
accordance with Th1 polarization.
Surprisingly, TSLP-DC polarized naive CD4 T cells to 
produce high amounts of IL-21 (Fig. 1 A). The amount of 
IL-21 induced by TSLP-DC polarization was similar to that 
of in vitro polarized Th17 cells. We recently showed that TSLP 
synergizes with CD40L in DCs to promote the expression 
of the Th17-polarizing cytokine IL-23 (Volpe et al., 2014). 
TSLP-DC induced low and inconsistent IL-17A secretion 
by CD4 T cells in comparison with in vitro–polarized Th17, 
Figure 1. tSLP-activated dcs polarize naive cd4 t cells into IL-21–secreting cells. Untreated DCs, treated with TSLP (TSLP-DC) or LPS (LPS-DC) were 
cultured with naive CD4 T cells for 6 d. (A) CBA (IL-4, IL-13, IFN-γ, and IL-17A) and ELI SA (IL-21) assays after 24 h of restimulation with anti CD3/CD28 beads. 
Th0, naive T cells cultured for 6 d with anti-CD3/CD28; Th17, Th0 plus Th17 polarizing cytokines (IL1β, IL-23, TGF-β, and IL-6). Data are mean ± SEM from 
nine independent experiments. (B) Intracellular FACS staining for IL-21, IFN-γ, TNF, and IL-4 for one representative donor. Gate is on activated DAPI− CD4 
T cells. (C) Quantification of data as in B. Data are mean ± SEM from six independent experiments. (D) Distribution of IL-21+ cells (red square) polarized by 
TSLP-DC coproducing IL-4, TNF, and IFN-γ. Filled histogram, isotype control; black line, IL-21 staining. Mean of six independent experiments. Single IL-21 
producers (16%) are not plotted. *, P < 0.05; **, P < 0.01; ***, P < 0.001, by Wilcoxon or Student’s t test.
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excluding a strong Th17 polarization by TSLP-DC. To check 
whether TSLP could act directly on CD4 T cell, in addition 
to DCs, we analyzed by FACS the expression of TSLP recep-
tor (R) chains (TSL PR and IL-7Rb) in naive CD4 T cells 
and DCs. DCs expressed high levels of both chains, whereas 
ex vivo or activated (5 d of anti CD3/CD28 beads, Th0 cells) 
naive CD4 T cells expressed IL7Rα but inconsistent levels 
of TSL PR (Fig. S1 A). We cultured sorted naive CD4 T cells 
with anti-CD3/CD28 beads and TSLP, in the absence of 
DCs. After 6 d of culture, we did not detect any induction of 
IL-21 by Th0 cells cultured either with or without TSLP. As 
a control, we detected IL-21 production by in vitro polarized 
Th17 (Fig. S1 B). Therefore, we concluded that TSLP was 
inducing IL-21 production by CD4 T cells through DCs.
Next, we investigated whether IL-21 was coproduced 
with other cytokines at the single T cell level. We performed 
intracellular staining for IL-21, in combination with IFN-γ, 
IL-4, and TNF as features of inflammatory Th2 differentiation 
induced by TSLP (Ito et al., 2005).  At day 6 of co-culture, 
∼30% of the CD4 T cells activated by TSLP-DC were pos-
itive for IL-21, indicating a strong IL-21 polarization. IL-21 
was mainly co-produced with TNF (20% of activated CD4 
Figure 2. IL-21 production by tSLP-dc–polarized cd4 t cells is stable. (A) DCs were activated with TSLP (50 ng/ml, TSLP-DC, filled triangles) or in 
control medium (DC, circles). After 24 h, DCs were co-cultured with naive CD4 T cells and stimulated for 24 h with anti-CD3/CD28 beads. IL-21 concen-
tration in the supernatants from seven independent experiments. (B) Quantification of IL-21 secretion by CD4 T cells polarized for 6 d with DCs, previously 
activated for 24 h with increasing doses of TSLP. SEM for four independent experiments; *, P < 0.05; **, P < 0.01; ***, P < 0.001, paired Student’s t test. 
(C) CD4 T cell fold expansion and IL-21 secretion from co-cultures with untreated CD1c+, TSLP-activated CD1c+ and TSLP-activated CD141+ DCs. SEM for 
12 independent experiments; *, P < 0.05; ***, P < 0.001, paired Student’s t test. (D) Intracellular FACS staining of IL-21, TNF, and IL-4 by TSLP-DC–activated 
CD4 T cells at the indicated days of primary and secondary culture from a representative CD4 T cell donor. In primary culture CD4 T cells were activated by 
TSLP-DC. In secondary culture, cells from day 5 of primary culture were cultured for 6 d in medium alone (No DC), with TSLP-DC or LPS-DC. (E) Percentage 
of IL-21+/TNF+ and IL-21+/IL-4+ cells (among activated cells) and fold expansion in primary and secondary culture as indicated, in three independent exper-
iments. NA, not applicable.
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cells). We identified IL-21+IL-4− (20%) and IL-21−IL-4+ 
(12%) populations, suggesting that distinct Th subsets arise in 
the presence of TSLP-DC (Fig. 1, B and C). To better char-
acterize the cytokine expression pattern of IL-21+ CD4 T 
cells after 6 d of co-culture with TSLP-DC, we calculated 
the percentage of cells coexpressing different combinations of 
cytokines. Among the IL-21+ cells, we detected a small pop-
ulation (5%) of Th cells coexpressing TNF, IL-4, and IFN-γ 
(Fig. 1 D). The majority (69%) of Th cells expressed IL-21 in 
combination with TNF (Fig. 1 D).
Next, we examined IL-21 induction by TSLP-DC in 
CD4 T cells. We detected IL-21 secretion after 3 d of DC/T 
cell co-culture (Fig. 2 A), using as low as 5 pg/ml TSLP to 
activate DCs (Fig. 2 B). We separately activated the CD1c+ 
and CD141+ DC subsets with TSLP. After co-culture with 
naive CD4 T cells, we observed that TSLP CD1c+ DCs in-
duced higher CD4 T cell expansion and IL-21 production, 
as compared with CD141+ DCs. We did not measure any 
significant difference between nontreated CD1c+ DCs and 
TSLP-CD141+ DCs with regards to IL-21 production and 
CD4 T cell expansion (Fig. 2 C).
Next, we investigated the stability of IL-21, TNF, and IL-4 
expression by TSLP-DC–activated CD4 T cells. We compared 
the intracellular expression of these cytokines by CD4 T cells 
cultured for 5 d in the presence of TSLP-DC (Fig. 2 D, pri-
mary culture), with the same CD4 T cells recultured for addi-
tional 6 d in medium without DCs (No DC), with TSLP-DC 
or LPS-DC (Fig. 2 D, secondary culture). The percentages of 
IL-21+TNF+ and IL-21+IL-4+ cells were comparable between 
the primary and secondary culture (Fig. 2 E), suggesting that the 
Figure 3. t cells polarized by tSLP-dc possess key features of human tfh cells. (A) ELI SA for CXCL13 production by CD4 T cells differentiated for 
6 d in co-culture with DCs, TSLP-DC, or LPS-DC. Cytokines secretion was measured after an additional 24 h of anti-CD3/CD28 bead stimulation. Data are 
mean ± SEM from 20 independent experiments. **, P < 0.01, paired Student’s t test. For the kinetic of CXCL13 expression, CD4 T cells were restimulated 
for 24 h with anti-CD3/CD28 beads after 3, 4, 5, or 6 d of co-culture with DCs (circles) or TSLP-DC (triangles). SEM for seven independent experiments. 
(B) FACS staining for ICOS, PD1, and CXCR5 in CD4 T cells after 4 d of co-culture with DCs. CXCR5hi/ICOShi and CXCR5hi/PD1hi cells within CD4 T DAPI− cells 
from a representative donor are shown. (C) Quantification of cell populations as indicated in B in naive CD4 T cells after 0, 2, 4, or 6 d of co-culture with 
DCs (circles), TSLP-DC (filled triangles), or LPS-DC (open triangles). SEM from six independent experiments. (D) CXCR5hi/PD1hi and CXCR5lo/PD1lo CD4 T cells 
polarized 4 d by TSLP-DC were sorted (top), and co-cultured with autologous memory B cells for 14 d. CD38 and CD27 were measured by FACS on B cells 
(DAPI−/CD3−/CD4−/CD19+). One representative plot is shown. (E) IgA, IgG, IgG4, and IgE were quantified in the supernatants of co-cultures, as in D, in the 
indicated conditions. Mean ± SEM for five donors. n.d., not detected. (F) Quantification of IgG and IgE in the supernatants of memory B cells co-cultured as 
in D, plus IL4R-α blocking or isotype control antibodies. SEM from five independent experiments are plotted. *, P < 0.05; **, P < 0.01, paired Student’s t test.
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expression of these cytokines was stable. Additionally, by count-
ing live cells we found that CD4 T cells activated by TSLP-DC 
expanded, even in the absence of further DC stimulation 
(Fig. 2 E, bottom). These two results suggested an overall ex-
pansion of the IL-21+TNF+ and IL-21+IL-4+ cell populations.
Thus, TSLP-DC promoted the generation of a stable, 
novel Th subset producing IL-21 and TNF, in combination or 
not with the Th2 cytokine IL-4.
th cells polarized by tSLP-dc possess 
features of human tfh cells
Because IL-21 is highly produced by Tfh cells (Schmitt et 
al., 2014), we asked whether TSLP-DC–polarized T helper 
cells had Tfh markers.
We measured the secretion of CXCL13, a chemokine 
produced by Tfh but not by other Th cell subsets (Kim et al., 
2004), after 6 d of co-culture followed by 24 h of anti-CD3/
CD28 stimulation. TSLP-DC, but not unstimulated DCs or 
LPS-DC, induced the secretion of CXCL13 by CD4 T cells 
(Fig. 3 A, top), suggesting Tfh polarization. CXCL13 secretion 
was detectable from day 5 of co-culture (Fig. 3 A, bottom).
A feature of human Tfh cells is the expression of high 
levels of the CXCL13 receptor CXCR5, in combination 
with high levels of ICOS and PD1 (Bryant et al., 2007; 
Crotty, 2014). We identified by FACS CXCR5high (hi)ICOShi 
and CXCR5hiPD1hi CD4 T cells after 4 d of co-culture with 
TSLP-DC (Fig. 3 B). TSLP-DC increased the percentage of 
CXCR5hiICOShi and CXCR5hiPD1hi populations at day 4 
as compared with day 2 and day 6 of co-culture, and in com-
parison to nonactivated DC and LPS-DC (Fig. 3 C). The use 
of naive T cells (CD4+CD25−CD45RA+CD45RO−) sorted 
to 99% purity, without detectable CXCR5+ cells (Fig. 3 C), 
Figure 4. t cells polarized by tSLP-dc 
show an expression pattern similar to ton-
sillar tfh cells. Heat map showing mRNA 
quantification of Tfh and Th markers in naive 
CD4 T cells, TSLP-DC–polarized CD4 T cells, 
and human tonsillar CD4 populations. CD4 T 
cells differentiated for 4 d with TSLP-DC were 
sorted as indicated (top left). Three popula-
tions of tonsillar CD4 cells were sorted (top 
right): CXCR5hi/PD1hi (GC Tfh), CXCR5int/PD1int 
(Tfh), and CXCR5−/PD1−. mRNA levels nor-
malized on the B2M and RPL34 housekeeping 
genes and center reduced are displayed on the 
heat map from five independent donors and 
two independent experiments.
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excluded that these cells originated from the rare blood 
memory Tfh population, characterized by CXCR5 expres-
sion (Morita et al., 2011).
One key function of Tfh cells is their ability to help B cells 
to secrete class-switched Igs (Crotty, 2014). To test whether the 
CXCR5hiPD1hi cells induced by TSLP-DC were able to help 
B cells, we sorted CXCR5hiPD1hi and CXCR5low(lo)PD1lo 
cells after 4 d of co-culture with TSLP-DC, and co-cultured 
them with autologous memory B cells (Fig. 3 D). We detected 
CD19+CD38hiCD27+ B cells after 14 d of co-culture with 
CXCR5hiPD1hi, but not with CXCR5loPD1lo T cells polar-
ized by TSLP-DC, similarly to the positive control of memory 
B cells activated by CD40-Ligand (CD40L) and CpG oligode-
oxynucletides type B (CpG-B; Fig. 3 D). At the same time point, 
we measured secretion of class switched Igs in the supernatants. 
Memory B cells activated with CD40L and CpG-B secreted 
IgA and IgG, as expected (Bernasconi et al., 2002). TSLP-DC 
polarized CXCR5hiPD1hi cells specifically induced IgG4 and 
IgE secretion by memory B cells. In comparison, IgA, IgG, and 
IgE secretion in the presence of CXCR5loPD1lo cells was low 
and inconsistent (Fig. 3 E). We measured lower amounts of IgA 
and IgG, induced by CXCR5hi/PD1hi cells as compared with 
memory B cells activated with CD40L and CpG-B (Fig. 3 E), 
in accordance with selective induction of IgE and IgG4.
Next, we investigated the mechanism by which 
TSLP-DC–induced CXCR5hiPD1hi cells promoted IgE se-
Figure 5. tSLP-induced cells express tfh 
markers. FACS analysis of BTLA (A), CD200 
(B), SAP (C), C-MAF (D), and CCR7 (E) in naive 
CD4 T cells and in TSLP-DC and LPS-DC acti-
vated cells at day 4 of co-culture with naive 
CD4 T cells. Isotype and specific staining for 
naive CD4 T cells and CXCR5hi/PD1hi and 
CXCR5lo/PD1lo population induced by TSLP-DC 
and LPS-DC is shown in histogram plot for one 
representative experiment. Quantification of 
MFI is plotted for three or four independent 
experiments. Naive CD4 T cells, filled diamond; 
TSLP-DC co-culture, filled triangles; LPS-DC 
co-culture, triangles. *, P < 0.05; **, P < 0.01; 
***, P < 0.001, paired Student’s t test.
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cretion by memory B cells. IL-4 mediates IgE production by 
human B cells (Pène et al., 1988). TSLP-DC–polarized T cells 
secreted IL-4 (Fig. 1 A). We functionally blocked IL-4 receptor 
α (IL-4Rb) in the co-culture of TSLP-DC–polarized T cells 
and memory B cells. After targeting of IL-4Rb by using a func-
tional blocking antibody, we were unable to detect IgE secre-
tion by memory B cells in the presence of TSLP-DC–polarized 
CXCR5hiPD1hi cells. In parallel, we detected an increase in IgG 
production (Fig. 3 F). As a control, we checked that IL-4Rb 
blocking antibody did not decrease B cell viability. Our data are 
in accordance with previous data showing that IL-4–reduced 
IgG production by human B cells (Nies et al., 2002).
Altogether, these results show that TSLP-DC induced the 
polarization of cells expressing Tfh markers such as CXCR5, 
PD1, and ICOS, and that these cells shared functional features 
of human Tfh2, comprising the ability to stimulate IgE secre-
tion by B cells. Mechanistically, we showed that IgE induction 
by TSLP-DC-polarized Tfh cells depended on IL-4Rb.
t cells polarized by tSLP-dc show molecular markers 
similar to tonsillar tfh
To confirm that TSLP-DC–polarized T cells presented fea-
tures of Tfh cells, we selected a set of Tfh markers on the 
basis of transcriptomic analysis of human Tfh cells (Kim et al., 
2004). We quantified the expression of these Tfh markers by 
qPCR on sorted CXCR5hiPD1hi and CXCR5loPD1lo CD4 
T cell populations identified among activated T cells after 4 d 
of co-culture with TSLP-DC (Fig. 4, top left). As a compar-
ison, we analyzed sorted naive CD4 T cells. CXCR5hiPD1hi 
cells expressed higher levels of Tfh markers at the mRNA 
level (BTLA, CXCR5, CXCL13, ICOS, PD1, SAP, CD200, 
and C-MAF) as compared with CXCR5loPD1lo cells (Fig. 4 
and Fig. S2). Additionally, CXCR5hi/PD1hi cells polarized by 
TSLP-DC expressed higher mRNA levels of the cytokines 
IL-21, IL-4, and TNF, as compared with CXCR5lo/PD1lo 
cells (Fig. 4). As expected, naive CD4 T cells did not express 
significant levels of Tfh markers.
Figure 6. cd4 t cells activated by tSLP-dc coexpress BcL6 and GAtA3. (A) FACS staining for BLC6, TBET, GATA3, and ROR GT in naive CD4 T cells 
co-cultured with TSLP-DC for 4 d. (B) Tonsillar CD4 cells analyzed as in A. Gates were set using fluorescence minus one plus isotype, and percentage of cells 
in each quadrant are shown for one representative donor. (C) Quantification of BCL6, TBET, GATA3, and ROR GT MFI in naive CD4 T cells and from data shown 
in A and B from three or five independent experiments. Empty squares, naive CD4 T cells; dots, TSLP-DC activated CD4; triangles, tonsillar CD4+ T cells. *, P < 
0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001, unpaired Student’s t test. (D) CD4 T cells sorted as CXCR5hiPD1hi at day 4 of co-culture with TSLP-DC were 
analyzed for intracellular expression of IL-4, IL-21, GATA3, and BCL6. One representative experiment is shown, and quantification of % of GATA3+/BCL6+ 
cells is plotted for four independent experiments. Mean ± SEM is plotted. *, P < 0.05; **, P < 0.01, paired Student’s t test.
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Notably, the expression pattern of Tfh markers paralleled 
the one of our positive controls, represented by sorted tonsillar 
GC Tfh (CD4+CD45RO+CXCR5hiPD1hi) and Tfh (CD4+ 
CD45RO+CXCR5loPD1lo), and differed from non-Tfh CD4 
(CD4+CD45RO+CXCR5−PD1−; Fig.  4). TSLP-induced 
CXCR5hi/PD1hi cells down-regulated the lymph node hom-
ing receptors CXCR4 and CCR7 at the mRNA level, sug-
gesting peripheral effector functions. As a control naive CD4 
T cells expressed CCR7 and CXCR4 mRNA.
Additionally, we measured the expression of BCL6, BLI 
MP, TBET, GATA3, ROR GT, and FOXP3, transcription 
factors orchestrating Th subset differentiation. The mRNA 
expression of BCL6, a transcriptional repressor import-
ant for Tfh polarization, was lower in CXCR5hiPD1hi than 
in CXCR5loPD1lo cells polarized by TSLP-DC (Fig.  4). 
CXCR5hiPD1hi cells induced by TSLP-DC expressed 
higher levels of TBET, GATA3, and ROR GT when com-
pared with CXCR5loPD1lo cells, similarly to tonsillar GC 
Tfh cells. Additionally, the CXCR5hiPD1hi cells induced by 
TSLP-DC did not express FOXP3, indicating that they were 
distinct from regulatory Tfh.
We measured by FACS analysis the expression of BTLA, 
CD200, SAP, and C-MAF proteins in naive CD4 T cells, as 
well as in CXCR5hiPD1hi and CXCR5loPD1lo cells, after 4 
d of co-culture in the presence of TSLP-DC and LPS-DC 
as a comparison (Fig. 5, A–D). CXCR5hiPD1hi cells induced 
by TSLP-DC expressed BTLA, CD200, SAP, and C-MAF at 
the protein level, thus validating our mRNA analysis. At the 
Figure 7. Memory cd4 t cells express tfh factors after activation by tSLP-dc. CD4 memory T cells were cultured with DCs, TSLP-DC, or LPS-DC, and 
cytokines were measured at the indicated days after 24 h of restimulation with anti-CD3/CD28 beads. ELI SA assay for IL-21 at day 6 of culture in A and at 
day 2, 4, and 6 in B. Mean ± SEM for 13 and 5 donors is shown, from four and two independent experiments, respectively. ELI SA assay for CXCL13 in C and 
CBA assay for Th cytokines in D in the same experimental settings as in B. (E and F) Memory CD4 T cells were separated into CXCR5+ and CXCR5− cells by 
FACS sorting, and cultured with DCs or TSLP-DC for 6 d. IL-21 and CXCL13 quantification after 24 h of anti-CD3/CD28 stimulation is shown as mean ± SEM 
from nine independent experiments. FACS staining for ICOS, PD1, and CXCR5 at day 6 of co-culture. BCL6 was quantified on the CXCR5hi/PD1hipopulation. 
The geometric MFI is plotted for three or two independent experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001, paired Student’s t test.
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protein level, we did not measure any significant difference in 
CCR7 protein levels between TSLP-induced CXCR5hiPD1hi 
and CXCR5loPD1lo. However, CCR7 protein expression 
was significantly higher in LPS-DC–induced CXCR5hiP-
D1hi cells as compared with TSLP-DC–induced (Fig. 5 E). 
As a negative control, naive CD4 T cells did not expressed 
BTLA, CD200, SAP, or C-MAF protein. As expected, naive 
CD4 T cells expressed surface CCR7 at similar levels that 
TSLP-induced CXCR5hiPD1hi and CXCR5loPD1lo cells.
Overall, CXCR5hiPD1hi cells polarized by TSLP-DC 
express markers characteristic of human tonsillar Tfh, sug-
gesting that TSLP-DC are able to induce Tfh polarization 
from naive CD4 T cells.
cXcr5hiPd1hi cells polarized by tSLP-dc 
coexpressed BcL6 and GAtA3
Our data showing the expression of BCL6, TBET, GATA3, 
and ROR GT by TSLP-DC activated CD4 T cells are rele-
vant to the coexistence of Th and Tfh polarization programs 
in a single cell. Therefore, we investigated their coexpression 
at the single-cell level.
We measured by intracellular FACS staining the expres-
sion of BCL6, TBET, GATA3, and ROR GT in CD4 T cells 
co-cultured for 4 d with TSLP-DC. We included, as a negative 
control, a CXCR5−PD1− population corresponding to cells 
that were co-cultured with TSLP-DC but did not display an 
activated profile (Fig.  6  A, bottom). We compared the ex-
pression of the same transcription factors in human tonsillar 
CD4 populations, identified by different expression levels of 
CXCR5 and PD1 (Fig. 6 B). TSLP-induced CXCR5hiPD1hi 
cells expressed significantly higher levels of BCL6, TBET, 
GATA3, and ROR GT protein when compared with CX-
CR5loPD1lo cells and naive CD4 T cells (Fig. 6, A and C). 
CXCR5hiPD1hi tonsillar cells expressed higher levels of BCL6, 
but lower levels of TBET, GATA3, and ROR GT, as com-
pared with TSLP-induced CXCR5hiPD1hi cells. These data 
validated that TSLP-DC–activated T cells expressed higher 
levels of lineage defining transcription factors, as suggested by 
our mRNA analysis of Fig. 4. CXCR5hiPD1hi cells, induced by 
TSLP-DC, expressed higher levels of BCL6 protein (Fig. 6 A) 
but lower levels of BCL6 mRNA (Fig. 4) as compared with 
CXCR5lo/PD1lo cells. One interpretation of this discrepancy 
is that there are some differences at the posttranscriptional 
level between CXCR5hi/PD1hi and CXCR5lo/PD1lo cells. 
Discrepancies between BCL6 mRNA and protein levels have 
been already reported (Kroenke et al., 2012).
Next, we investigated whether the IL-4+IL-21+ cells 
we characterized (Fig.  1) coexpressed BCL6 and GATA3. 
We FACS sorted CXCR5hiPD1hi cells and analyzed the ex-
pression of IL-4, IL-21, BCL6, and GATA3 by intracellular 
FACS staining. The majority (80%) of IL-4+IL-21+ cells co-
expressed BCL6 and GATA3 proteins, as shown by a repre-
sentative donor and quantification in Fig. 6 D. BCL6/GATA3 
double-positive population was significantly enriched in 
IL-4+IL-21+ cells compared with single cytokine producers 
or double-negative cells. This showed that TSLP-DC–ac-
tivated CXCR5hiPD1hiIL-21+IL-4+ cells preferentially co-
expressed BCL6 and GATA3.
Overall, these data showed that TSLP-DC–induced the 
expression of BCL6 in combination with Th lineage defining 
transcription factors, in particular GATA3, at the protein level.
IL-21 and cXcL13 secretion from memory cd4 t cells 
are increased by tSLP-dc
TSLP-DC are potent inducers of memory Th2 responses 
(Wang et al., 2006). To establish whether TSLP-DC stimu-
lated IL-21 and CXCL13 secretion by memory CD4 T cells, 
we cultured TSLP-DC with allogeneic memory CD4 pu-
rified by sorting (99% purity) from healthy donor periph-
eral blood (CD4+CD25−CD45RA−CD45RO+). Memory 
CD4 T cells secreted increased amounts of IL-21 after 6 d 
of co-culture in the presence of TSLP-DC, when compared 
with CD4 memory co-cultured with untreated DCs or 
LPS-activated DCs (Fig. 7 A).
To gain insight into the dynamic of cytokine secretion 
by memory T cells activated by TSLP-DC, we washed and 
restimulated cells after 2, 4 or 6 d of co-culture. IL-21 se-
cretion by memory CD4 T cells was detected after 2 d of 
co-culture with TSLP-DC, and was higher after 4 and 6 d 
(Fig. 7 B). CXCL13 was induced at day 6 of co-culture, but 
barely detectable before (Fig. 7 C). We compared the expres-
sion of IL-21 and CXCL13 with the expression of Th2 cy-
tokines (IL-3, IL-4, and IL-5) in the same experiment. IL-3 
was induced at day 2, whereas the secretion profiles of IL-4 
and IL-5 over time were comparable to the one of CXCL13 
(Fig. 7 D, left column). In the same settings, we were unable to 
detect any statistically significant difference in TNF secretion 
(Fig. 7 D, right column). The secretion profiles of IL-21 and 
CXCL13 were different from the ones of IL-17A and IFN-γ 
(Fig. 7 D, right column), characteristics of Th17 and Th1 cells, 
respectively. This indicated that TSLP-DC–activated memory 
CD4 T cells to express Tfh cytokines IL-21 and CXCL13 
with a kinetic of secretion similar to Th2 cytokines.
Detection of CXCL13 and IL-21 in the co-culture of 
memory CD4 T cells with TSLP-DC suggested that memory 
Tfh, which have been described as CXCR5+CD4+CD45RA− 
CD45RO+ cells in human peripheral blood (Morita et al., 
2011), might be activated by TSLP-DC. To test this hypothe-
sis, we sorted blood memory CD4 based on CXCR5 expres-
sion, and co-cultured the CXCR5− and CXCR5+ memory 
CD4 populations separately with either nonactivated DCs or 
TSLP-DC (Fig.  7  E, top). TSLP-DC significantly induced 
IL-21 and CXCL13 secretion by CXCR5+ memory Tfh in 
comparison to nonactivated DCs after 6 d of co-culture, fol-
lowed by 1 d of restimulation with anti-CD3/CD28 beads 
(Fig. 7 E). At day 6, we measured by FACS the expression 
of ICOS, PD1, CXCR5, and BCL6 in the same experimen-
tal conditions as in Fig. 7 E. TSLP-DC significantly induced 
ICOS, CXCR5, and BCL6 compared with unstimulated 
DCs (Fig. 7 F) in memory CXCR5− cells.
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Overall, we concluded that TSLP-DC preferentially stim-
ulated CXCR5+ CD4 T cells to secrete IL-21 and CXCL13. 
Additionally, TSLP-DC induced expression of ICOS, CXCR5, 
and BCL6 on CXCR5− memory CD4 T cells.
tSLP-dc induce IL-21 and cXcL13 
production through oX40L
To gain mechanistic insight into TSLP-DC induction of IL-21 
and CXCL13 expression, we focused on the Th-polarizing 
molecules induced by TSLP in DCs. Because TSLP-DC pro-
duce low levels of inflammatory cytokines, and no IL-12 
(Soumelis et al., 2002), we explored the contribution of sur-
face co-stimulatory molecules associated with Tfh differen-
tiation. We measured by flow cytometry the expression of 
CD86, PDL1, ICO SL, and OX40L on DCs cultured for 48 h 
with TSLP, LPS, or untreated.
We observed that TSLP-DC expressed high levels of 
ICO SL (Fig. 8, A and B), a molecule important in Tfh po-
larization (Choi et al., 2011). To assess the role of ICO SL, we 
cultured TSLP-DC with CD4 T cells in the presence of an 
anti-ICO SL blocking antibody and measured cytokines after 
6 d. ICO SL blocking did not affect IL-3 or IL-10 levels, and 
more importantly, did not inhibit polarization by TSLP-DC 
into Th cells secreting IL-21 and CXCL13 (Fig. 8 C). As a 
control of the functional blocking of the ICO SL antibody, 
we detected a decrease in IL-10 production by naive CD4 T 
cells cultured with plasmacytoid DCs activated with CpGB 
(pDCs; Fig. 9 A), as previously reported (Ito et al., 2007).
We confirmed OX40L as being induced by TSLP in 
comparison to DCs or LPS-DC (Fig.  8  A and quantifica-
tion in Fig.  8  B; Ito et al., 2005). Given the controversial 
role of OX40L in mouse Tfh development (Deenick et al., 
2011), and a recent study on the role of OX40L in human 
Tfh polarization (Jacquemin et al., 2015), we investigated 
its role in TSLP-DC–induced Tfh polarization. We used an 
anti-OX40L blocking antibody during the TSLP-DC CD4 
T cell co-culture. OX40L blocking inhibited IL-3 secretion, 
whereas enhancing IL-10 expression (Fig. 8 D), as previously 
Figure 8. tSLP-dc induce IL-21 and cXcL13 production through oX40L. (A) FACS analysis of surface expression of CD86, PDL1, ICO SL, and OX40L 
by DCs cultured without any stimulation (NT), TSLP, or LPS for 48 h. Filled gray histogram shows matched isotype control. Black histogram shows antibody 
staining. One representative donor is shown. (B) Quantification of MFI as in A. Mean ± SEM for seven experiments. (C) Quantification of cytokine by CBA 
(IL-3 and IL-10) or ELI SA (CXCL13 and IL-21) by CD4 T cells differentiated during 6 d with DCs or TSLP-DC. Anti-ICO SL blocking antibody or isotype control 
antibody (25 µg/ml) were kept all along the culture. Mean ± SEM for four experiments, is plotted. D) Cells were cultured as in C, and instead of ICO SL block-
ing antibody, an anti-OX40L antibody or isotype control (50 µg/ml) were used. Mean ± SEM for seven experiments. *, P < 0.05; **, P < 0.01; ***, P < 0.001, 
paired Student’s t test.
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reported (Ito et al., 2005). We found that OX40L inhibition 
significantly decreased both CXCL13 and IL-21 secretion by 
CD4 T cells polarized by TSLP-DC (Fig. 8 D). We investi-
gated the effect of ICO SL and OX40L functional blocking 
on the expression of CXCR5, PD1, and BCL6. We mea-
sured the percentage of CXCR5hiPD1hi and CXCR5loPD1lo 
cells, and their respective expression of BCL6 in the pres-
ence of blocking antibodies and isotype controls, after 4 d 
of co-culture with TSLP-DC. ICO SL functional blocking 
increased BCL6 expression by CXCR5hiPD1hi cells com-
pared with the isotype control (Fig. 9 B, and quantification in 
D). OX40L functional blocking decreased the percentage of 
CXCR5loPD1lo cells, paralleled by an increase in the percent-
age of CXCR5hiPD1hi cells (Fig. 9 C). In line with no signif-
icant changes in IL-21 and CXCL13 expression (Fig. 8 D), 
we could not observe any decrease of BCL6 expression in 
response to ICO SL functional blocking (Fig. 9 D). However, 
we observed that OX40L functional blocking induced a sig-
nificant decrease of BCL6 expression in both CXCR5loPD1lo 
and CXCR5hiPD1hi cells polarized by TSLP-DC (Fig. 9 D).
In summary, our data demonstrated that TSLP induced 
Tfh polarization through OX40L, and that OX40L con-
trolled BCL6 expression.
In vivo evaluation of tfh markers in atopic dermatitis (Ad) 
and netherton syndrome (nS) patients
We sought to assess the relevance of the TSLP-DC–polarized 
Tfh cells in human pathology. AD is a skin allergic pathology 
characterized by Th2 environments (Brandt and Sivaprasad, 
2011), and the role of TSLP in the pathogenesis of AD is well 
established (Ziegler and Artis, 2010).
We first asked whether Tfh were infiltrating the lesional 
skin of AD patients. By immunofluorescence, we could not detect 
CXCL13+ cells in frozen AD skin sections (Fig. S3 A). By FACS, we 
identified very low percentages (<0.5%) of CXCR5+ CD4+ cells 
in T cell emigrated from lesional skinbiopsies of 2 AD donors (Fig. 
S3 B). Lack of significant Tfh cell infiltration of AD skin prompted 
us to look for circulating Tfh within AD PBMCs. Circulating 
human Tfh cells comprise a population of IL-4– and IL-21–pro-
ducing cells that induce IgE switch in B cells (Morita et al., 2011).
We quantified by FACS the percentage of this Tfh subset 
cells, gated as CD4+CD45RO+CXCR5+CXCR3−CCR6−, 
in PBMCs obtained from age- and gender-matched AD 
and healthy donors. The percentage of Tfh2 was higher in 
AD donors as compared with healthy donors (64 vs. 30% of 
CXCR5+CD45RA+CD4+ cells). In parallel, we observed a 
dramatic decrease of CXCR3+CCR6−cells (Fig. 10 A).
Figure 9. oX40L blocking reduces BcL6 
induction by tSLP-dc. (A) Quantification 
of IL-10 production using CBA by CD4 T cells 
differentiated during 6 d with pDC activated 
with CpGB (15 µg/ml during 24 h). Anti-ICO SL 
blocking antibody or isotype control antibody 
(25 µg/ml) were added at the beginning of 
the culture. Mean ± SEM for six experiments 
is plotted. *, P < 0.05 Wilcoxon matched pair 
test. (B) Quantification by FACS analysis of 
the percentage of CXCR5hiPD1hi, CXCR5loPD1lo 
cells in TSLP-DC co-culture at day 4, treated 
with functional blocking antibodies or isotype 
controls as indicated. The percentage of each 
gate is shown. For BCL6 expression, gray histo-
grams represent the FMO signal, and red his-
tograms represent specific BCL6 staining. MFI 
of specific staining and percentage of BCL6+ 
cells are plotted for one representative exper-
iment. (C and D) Quantification as in B, from 
six independent experiments. SMFI for BCL6 
was calculated by subtracting the FMO from 
BCL6-specific staining in CXCR5hiPD1hi and 
CXCR5loPD1lo cells. *, P < 0.05; **, P < 0.01; ***, 
P < 0.001, paired Student’s t test.
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In addition to AD, which includes predominantly local 
inflammatory manifestations, we looked for a systemic dis-
ease in which TSLP is expressed. This is the case of NS, a 
rare genetic skin disease characterized by a severe skin barrier 
defect, atopic manifestations, and elevated IgE levels (Hovna-
nian, 2013). It has recently been shown that TSLP is highly 
expressed in a mouse model for NS and in the skin of NS 
patients (Briot et al., 2009). We analyzed the levels of TSLP in 
64 serum samples obtained from 13 NS patients by ELI SA. In 
parallel, we measured CXCL13 as a Tfh marker in the same 
samples. We found a significant positive correlation between 
TSLP and CXCL13 in the sera of NS patients (Fig. 10 B).
Collectively, AD and NS patient samples suggest that 
TSLP and Tfh might be linked in humans in vivo.
dIScuSSIon
In this study, we provide definitive evidence for a key role 
of TSLP-activated DCs in the differentiation of naive CD4 
T cells into cells possessing Tfh characteristics through the 
co-stimulatory molecule OX40L.
IL-12, the main driver of Th1 polarization, promotes Tfh 
differentiation in humans (Schmitt et al., 2009, 2013; Ma et 
al., 2012). It has been recently shown that the Th17-inducing 
cytokines IL-23 and TGF-β could trigger Tfh differentiation 
too (Schmitt et al., 2014). However, Tfh cells are also present 
in Th2-dominated environments (Glatman Zaretsky et al., 
2009; Yusuf et al., 2010; Liang et al., 2011; Kemeny, 2012), 
and may have an important physiopathological role in mouse 
models of airway hyperresponsiveness (Coquet et al., 2015; 
Ballesteros-Tato et al., 2016). However, how Tfh differentia-
tion can occur in such Th2 environments is not known. The 
cytokine TSLPwas until now associated with human Th2 po-
larization (Liu et al., 2007; Ziegler and Artis, 2010). Here, we 
show a novel function of TSLP as the driver of the differentia-
tion of Tfh cells expressing CXCR5, IL-21, CXCL13, BCL6, 
and helping memory B cells to produce IgG and IgE. How 
to reconcile the induction of Tfh cell differentiation in a Th2 
context, and the reported negative role of IL-4 on human Tfh 
development (Schmitt et al., 2014), must still be answered. In 
our data, we observed a co-occurrence of IL-21– and IL-4–
producing T cells in TSLP-DC–polarized cultures. However, 
TSLP-DC do not produce IL-4 (Soumelis et al., 2002), and 
TSLP-DC–activated T cells start secreting IL-4 around day 4 
(Leyva-Castillo et al., 2013), when we could already iden-
tify the CXCR5hiPD1hi population of cells expressing Tfh 
markers. Therefore, there is an IL-4–free window for Tfh 
differentiation during the first 48 h of culture, a time when 
the decision making about Tfh differentiation likely occurs 
(Choi et al., 2011). Importantly, IL-4 inhibits IL-21 secre-
tion in DC-free settings (Schmitt et al., 2014), different from 
our DC/T cell co-cultures. We cannot exclude the possibil-
ity that, in the context of TSLP-DC–driven Tfh polarization, 
IL-4 might not inhibit IL-21 production.
The relationship and plasticity between Tfh and Th 
subsets are still debated. Here, we show that TSLP-DC–in-
duced CXCR5hiPD1hiIL-21+IL-4+ cells coexpressed the Th2 
transcription factor GATA3 and the Tfh transcription factor 
BCL6. Our data suggest that, in TSLP-DC–activated cells, 
Figure 10. In nS patients, serum tSLP levels positively correlate with cXcL13. (A) FACS analysis showing the frequency of CCR6−CXCR3− (green), 
CCR6−CXCR3+, and CCR6+CXCR3− populations in the CD4+CD45RO+CXCR5+ gate. Representative plots are shown for a healthy donor and AD donor, respec-
tively. Frequency distribution in six AD donors, and four healthy donors are plotted. *, P < 0.05; **, P < 0.01; ***, P < 0.001, paired Student’s t test. (B) Linear 
correlation between serum TSLP and CXCL13, measured by ELI SA, is shown. Spearman r and P-values are plotted. 64 samples from 13 NS patients are plotted.
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GATA3 drives IL-4 expression in the presence of BCL6. In 
contrast, previous observations showed that BCL6 represses 
GATA3 in GC Tfh (Kusam et al., 2003; Hatzi et al., 2015). 
From our data, we could not elucidate the mechanisms un-
derlying GATA3 and BCL6 coexpression. However, our 
cellular system, based on human primary cells, represents a 
unique tool to understand the relationship and plasticity be-
tween Th2 and Tfh in humans.
Co-stimulatory molecules, in particular ICOS–ICO SL 
interactions, were shown to be important in Tfh cell devel-
opment (Choi et al., 2011; Crotty, 2014). The role of other 
co-stimulatory molecules, and in particular OX40L, is contro-
versial and seems to depend on the experimental mouse model 
used (Deenick et al., 2011). A recent work shows that OX40L 
promotes human Tfh responses, particularly in Lupus (Jacque-
min et al., 2015). In our work, by using functional blocking of 
co-stimulatory molecules, we established that OX40L, and not 
ICO SL, is the main driver of IL-21, CXCL13, and BCL6 ex-
pression in T cells by TSLP-DC. Nonetheless, as OX40L func-
tional blocking did not completely abolish IL-21 and CXCL13 
production, we cannot exclude that other factors may con-
tribute to the induction of Tfh differentiation by TSLP-DC.
We show that TSLP-DC not only stimulated naive 
CD4 T cells to acquire Tfh markers, but strongly induced 
IL-21 and CXCL13 secretion by memory circulating Tfh 
cells. Additionally, TSLP-DC induced the expression of Tfh 
markers ICOS, PD1, CXCR5 and BCL6 in memory non 
Tfh (CXCR5−) cells . This result is particularly relevant to 
Tfh biology because, to our knowledge, this is the first report 
of reprogramming of human memory non-Tfh CD4 T cells 
into Tfh-like cells. The frequency of memory circulating Tfh 
and their activation states have been linked to antibody re-
sponses in human subjects (He et al., 2013; Locci et al., 2013). 
Therefore, it has been proposed that boosting memory Tfh 
responses could improve vaccine efficacy (Ma and Deenick, 
2014). Our study, in combination with published data on the 
effect of TSLP on mouse antibody responses (Van Roey et 
al., 2012), provides the rationale to further explore TSLP as a 
vaccine adjuvant in humans. Additionally, our findings suggest 
that TSLP, which is produced by epithelial cells, could activate 
memory Tfh cells in inflamed peripheral tissues through DCs.
How CXCR5hiPD1hi CD4 cells induced by TSLP-DC 
relate to reported Tfh subsets is of major importance. We di-
rectly compared CXCR5hiPD1hi cells polarized by TSLP-DC 
to human tonsillar Tfh (Kim et al., 2004; Bryant et al., 2007; 
Weinstein et al., 2014). Our data show that the expression 
profile of key Tfh markers (PD1, CXCR5, ICOS, BTLA, 
SAP, CD200, CXCL13, IL-21, C-MAF, BCL6, and BLI MP1) 
by TSLP-DC–induced CXCR5hiPD1hi cells was similar to 
tonsillar Tfh and GC Tfh cells.
A characteristic of the IL-21+ cells we identified, dis-
tinguishing them from previously reported Tfh subsets, is the 
co-production of TNF. 20% of CD4 activated by TSLP-DC 
coexpressed IL-21 and TNF. We propose that IL-21+TNF+ 
cells may correspond to a distinct inflammatory Tfh cell 
subset. In addition, we also detected cells producing IL-21, 
but not IL-4, TNF, or IFN-γ (16% of IL-21 producers), 
IL-21+IL-4+ (3% of IL-21 producers), and IL-21+IL-4+TNF+ 
(11% of IL-21 producers). This reveals that TSLP induced a 
large diversity of Th cells, with potential diverse functions 
depending on the physiopathological contexts. We observed 
the co-induction of IFN-γ+ cells, a hallmark of Th1 cells, 
together with Th2 effector cells. This co-induction repro-
duces the coexistence of Th1 and Th2 cells in AD (Grewe 
et al., 1998), where TSLP plays a role in T cell polarization 
(Ziegler and Artis, 2010).
By co-culturing CXCR5hiPD1hi and CXCR5loPD1lo 
cells polarized by TSLP-DC with memory B cells, we 
showed that CXCR5hiPD1hi cells selectively induced IgE 
secretion. Therefore, in addition to Tfh markers, cells polar-
ized by TSLP-DC presented Tfh2 functional features (Ueno 
et al., 2015). We found that IgE secretion was accompanied 
by IgG4 production. Both IgE and IgG4 have been linked to 
allergic disorders in humans (Gould et al., 2003). Mechanis-
tically, using anti-IL-4Rb functional blocking antibody, we 
showed that IgE induction depended on IL-4 and/or IL-13. 
Therefore, we described a pathway linking TSLP to IgE pro-
duction, and involving interactions between epithelial cells, 
DCs, T cells and B cells.
TSLP is expressed in a broad spectrum of diseases. This 
is the case of AD (Soumelis et al., 2002), psoriasis (Volpe et al., 
2014), NS (Hovnanian, 2013; Furio and Hovnanian, 2014), 
keloid (Shin et al., 2016), and helminthic infections (Rama-
lingam et al., 2009; Ziegler and Artis, 2010; Giacomin et al., 
2012). In some of these diseases, Tfh cells have been reported 
(Glatman Zaretsky et al., 2009; Niu et al., 2015). Our analysis 
on AD clinical samples show that there is an enrichment of 
Tfh2 and a decrease of Tfh1 in the circulation. A decrease in 
Th1 cells in PMBC of chronic AD patients has been previ-
ously shown (Nakazawa et al., 1997; Lonati et al., 1999). In 
NS serum samples, we found a positive correlation between 
TSLP and the GC activity marker CXCL13.
Collectively, our study provides the rationale to exploit 
TSLP as a pharmacological target to manipulate Tfh polar-
ization in allergic and inflammatory disorders. Acting on an 
upstream inducer mechanism of Tfh and Tfh2 differentia-
tion may result in additional clinical benefit in the complex 
pathogenicity of allergy.
MAtErIALS And MEtHodS
cell purification
Buffy coats were obtained from healthy adult blood donors 
(Etablissement Français du Sang, Paris, France) in conformity 
with Institut Curie ethical guidelines. Human blood pri-
mary DCs were purified according to an established protocol 
(Alculumbre and Pattarini, 2016). In brief, after FIC OLL 
(GE Healthcare) gradient centrifugation, total PBMCs were 
enriched in DCs using the EasySep Human Pan-DC Pre- 
Enrichment kit (StemCell Technologies). Enriched DCs were 
sorted to obtain 98% purity on a FAC SVantage (Miltenyi 
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Biotec), as Lineage (CD3, CD14, CD16, and CD19)− CD4+ 
(Beckman Coulter), CD11c+ (BioLegend), whereas pDCs 
were sorted as Lineage− CD4+ CD11c−. When detailed, DCs 
were further separated into subsets by FACS sorting using 
anti CD1c (eBioscience) and CD141 (Miltenyi Biotec) stain-
ing. After enrichment from total PBMCs using the CD4+ T 
cell isolation kit (Miltenyi Biotec), naive and memory CD4 
T cells were sorted on a FAC SAR IA (BD) as CD4+, CD25−, 
and CD45RA+ and CD45RO+, respectively (BD). Blood Tfh 
were sorted as CD4+CD25−CD45RO+CXCR5+ (R&D Sys-
tems). Human tonsils were obtained from the Necker Hos-
pital (Paris, France) in conformity with Institut Curie ethical 
guidelines. Tonsillar CD4 T cells were purified from human 
tonsils by mechanical disruption (C tube and gentleMACS, 
Miltenyi), followed by a FIC OLL gradient centrifugation. 
For FACS analysis, total cells were analyzed. For PCR analy-
sis, tonsillar Tfh were enriched using a CD4+ T cell isolation 
kit (Miltenyi) and then sorted as CD4+, CD19−, CD45RO+, 
CXCR5hi/lo/-, and PD1hi/lo/- (BioLegend) on a FAC SAR IA (BD).
dc and pdc activation
DC and pDC were cultured in RPMI 1640 Medium Gluta-
MAX (Life Technologies) containing 10% Fetal Calf Serum 
(Hyclone), 100 U/ml Penicillin/Streptomycin (Gibco), 
MEM Non-Essential Amino Acids (Gibco), and 1 mM NA 
pyruvate (GIB CO). DCs were cultured at 106/ml in flat bot-
tom plates for 24 h in the presence of 50 ng/ml rhTSLP- 
where not differently specified (R&D Systems) or 100 ng/ml 
ultrapure LPS (InvivoGen).
pDCs were cultured at 106/ml in flat-bottom plates for 
24 h in the presence of 15 µg/ml CpGB ODN 2006 (InvivoGen).
dc/t co-culture
For co-culture, DCs were washed twice in PBS and put in 
culture with allogeneic either naive or memory CD4 (104 
DCs and 5 × 104 T cells) in X-VIVO 15 medium (LON ZA) 
for the indicated time. For co-culture, pDC were washed 
twice and put in culture with allogeneic naive CD4 cells 
(104 pDC and 5 × 104 T cells) in Yssel’s medium for 6 d. For 
co-culture, CD4 T cells were freshly purified from PBMC 
the day after DC purification. Each co-culture experiment 
was performed by coupling exclusively a single DC donor 
with a single CD4 T cell donor.
For blocking experiments, DCs or pDCs were incubated 
at 37°C with 50 µg/ml anti–human OX40L antibody (clone 
ik-5; provided by T. Hori, Ritsumeiken University, Japan), 25 
µg/ml anti–human ICO SL (clone MIH-12; eBioscience), or 
matched isotype controls (R&D Systems and eBioscience). 
After 60 min, CD4 naive T cells were added to the culture. 
Antibodies were maintained for the duration of the co-culture.
At indicated time points, cells were either FACS sorted 
or used for surface or intracellular staining, or washed and 
reseeded at 106/ml and treated with anti-CD3/CD28 beads 
(LifeTech) for 24 h, after which supernatants and cells were 
collected for analysis.
For primary and secondary co-cultures, CD4 naive T 
cells were co-cultured with DCs as described at the begin-
ning of this section. At day 5, cells were counted and divided. 
One part was analyzed for intracellular cytokine production; 
the other part was put in a secondary culture in the absence 
of any DCs, in the presence of TSLP-DC or LPS-DC (24 h 
activation), at the ratio 1:5 in X-VIVO 15 medium. DCs used 
in the secondary co-culture were purified from donors inde-
pendent from the DC donors of the primary co-culture and 
the CD4 T cell donors. Cells were kept in culture for 6 d, and 
half of the medium was replaced at day 5 with fresh medium.
dc-free th cell polarization
Sorted naive CD4 T cells were cultured with anti CD3/CD28 
beads to obtain Th0 or beads plus IL-1β, IL-23, TGF-β, and 
IL-6 (PeproTech) to obtain Th17 as already published (Volpe 
et al., 2008) for 5 d. When indicated, 50 ng/ml TSLP was 
added at the beginning of the culture, and cells were cultured 
for 6 d. At the end of the culture, cells were washed, reseeded 
at 106/ml, and treated with anti-CD3/CD28 beads; superna-
tants and cells were collected for analysis after 24 h.
t/B co-culture
After 4 d of co-culture with TSLP-DC, activated CD4 T cells 
were FACS sorted as CXCR5hi/PD1hi or CXCR5lo/PD1lo. 
The same day, autologous PBMC were thawed and, after a 
round of human memory B cell Enrichment (Miltenyi Bio-
tec), memory B cells were FACS sorted as CD3−CD19+C-
D27+IgD− cells. T and B cells were co-cultured in X-VIVO 
medium in round-bottom plates (2.5 × 105 T and 2.5 × 105 
memory B). Memory B cells alone were cultured with 1 µg/
ml rhCD40L (Alexis) and 2.5 µg/ml CpG B or left untreated. 
At day 14 of culture, cells were harvested for flow cytometry 
analysis and supernatants stored at −80°C to quantify Igs.
For IL4R-α functional blocking, sorted CXCR5hi/
PD1hi or CXCR5lo/PD1lo cells were incubated at 37°C 
with 20 µg/ml of anti–IL4R-α or IgG2a isotype control 
(R&D Systems). After 1  h, autologous-sorted memory B 
cells were added (2.5 × 105 T cells and 2.5 × 105 memory 
B cells). Supernatants were recovered after 14 d of co-cul-
ture, stored at –80°C for IgG and IgE measurement by cyto-
metric bead array (CBA).
Flow cytometry analysis
Antibodies and matched isotypes were titrated on the relevant 
human PBMC population. For surface FACS analysis, the an-
tibodies recognizing these proteins were used: PDL1 (BD), 
CD86 (BD), OX40L (Ancell), ICO SL (R&D Systems), ICOS 
(eBioscience), PD1 (BD), CXCR5 (R&D Systems or BD), 
BTLA (BioLegend), CD200 (eBioscience), CCR7 (BD), 
TSL PR (BioLegend), IL7Ra (eBioscience), CD27 (BD), and 
CD38 (Miltenyi Biotec). Dead cells were excluded using 
DAPI (Miltenyi Biotec).
For intracellular cytokine staining, CD4 T cells were 
stimulated with 100 ng/ml PMA plus 500 ng/ml Ionomy-
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cin. When cells were sorted before intracellular staining, 
they were cultured overnight in X-VIVO medium at 106 
cells/ml before PMA and Ionomycin stimulation. After 90 
min, 3 µg/ml Brefeldin A (eBioscience) was added and kept 
for 4  h. To exclude dead cells, CD4 T cells were stained 
using the LIVE/DEAD Fixable yellow dead cell stain kit, 
following manufacturer’s instructions (LifeTech). Cells 
were fixed and permeabilized using the IC Fix and Per-
meabilization buffers (eBioscience). Intracellular cytokines 
were revealed with fluorescently conjugated antibodies 
against IL-21 (BD), TNF (BioLegend), IL-4, and IFN-γ, or 
matched isotype controls (eBioscience) and acquired on a 
LSR Fortessa instrument (BD).
For transcription factor intracellular staining, dead 
cells were first stained with a Zombie-NIR dye (BioLeg-
end), followed by PD1 and CXCR5 (BD) staining. After 
fixation and permeabilization using the FOXP3 IC buffer 
kit (eBioscience), cells were stained with an anti-BCL6 
antibody (BD), TBET, GATA3, RORC, C-MAF, or SAP 
(eBioscience) and acquired on a LSR Fortessa instrument. 
As a control for intracellular staining of transcription factors, 
cells were stained using PD1, CXCR5, and CD4 (to define 
the populations) and matched isotype controls at the same 
concentration as the transcription factor antibodies. The flu-
orescence obtained in each channel and in each population 
in the presence of isotype control antibody (Fluorescence 
minus one [FMO]) was subtracted from the fluorescence 
obtained by the specific staining of transcription factors in 
each population. Sorted naive CD4 T cells were analyzed 
in parallel as a control.
Flow cytometry data processing
FACS data were analyzed using the FlowJo software (Tree Star).
cytokine quantification
Cytokines were quantified in the supernatants using ELI 
SA for IL-21 (BioLegend) and CXCL13 (R&D Systems) or 
CBA flex set for IL-3, IL-4, IL-5, IL-10, IL-13, IL-17A, TNF, 
and IFN-γ (BD), following the manufacturer’s protocol. Total 
human IgG, IgE, IgG4, and IgM were quantified using the 
Human IgGs Flex Sets (BD).
Pcr
Cells were sorted and lysed in RLT buffer. RNA extraction 
was performed using the RNAeasy micro kit (QIA GEN) 
according to manufacturer’s instructions. Total RNA was 
retrotranscribed using the superscript II polymerase (In-
vitrogen) in combination with random hexamers, oligo 
dT, and dNTPs (Promega).
Transcripts were quantified by real time PCR on a 
480 LightCycler instrument (Roche). Reactions were per-
formed in 10  µl, using a master mix (Eurogentec), with 
the following TaqMan Assays (all from Life Technologies): 
BCL6 (Hs00153368_m1), PRMD1 (Hs00153357_m1), 
BTLA (Hs00699198_m1), CXCR4 (Hs00607978_s1), 
CXCR5 (Hs00540548_s1), CXCL13 (Hs00757930_m1), 
ICOS (Hs00359999_m1), IL-21 (Hs00222327_m1), 
PDCD1 (Hs01550088_m1), SH2D1A (Hs00158978_m1), 
CCR7 (HS 00171054_m1), CD200 (Hs01033303_m1), 
IL-4 (Hs00174122_m1), TNF (Hs00174128_m1), MAF 
(Hs00193519_m1), GATA-3 (Hs00231122_m1), TBX-21 
(Hs00203436_m1), RORC (Hs01076112_m1), FOXP3 
(Hs00203958_m1), IL-5 (Hs00174200_m1), IL-13 
(Hs99999038_m1), IFNG (Hs00174143_m1), and IL-17A 
(Hs00174383_m1). Crossing points (Cp) from each analyte 
were obtained using the second derivative maximum method, 
and the transcripts were quantified as fold changes in com-
parison to the mean of the two housekeeping genes (B2M 
[Hs99999907_m1] and RPL34 [Hs00241560_m1]).
Analysis of Ad and Hd PBMcs
After obtaining informed consent from patients, whole blood 
was taken from AD patients (n = 6, Table 1). PBMCs were pu-
rified using CPT tubes (BD) and immediately frozen. Local 
ethics committees of the Heinrich-Heine University (Dus-
seldorf, Germany) approved the study. Healthy age- and gen-
der-matched controls were also included in the study, and were 
processed as AD samples at the Heinrich-Heine University.
Total PBMCs from healthy donors and from AD pa-
tients (5 × 106 each), where thawed and immediately stained 
for sorting. Cells were stained using CD4 (BD), CD45RO 
(BD), CXCR5 (R&D Systems), CXCR3 (BD), and CCR6 
(BioLegend) for 30 min at 37°C.
Table 1. clinical data
Patient no. Gender Year of birth Diseases SCO RAD
1 M 1975 AD 41
2 W 1957 AD 41
3 M 1962 AD 39
4 W 1997 AD 35.4
5 W 1998 AD 38.2
6 W 1989 AD 44.4
7 M 1980 HD
8 W 1970 HD
9 W 1987 HD
10 W 1969 HD
M, man; W, woman. SCO RAD (Scoring of AD) was assessed following the Consensus report of the European task force on AD. 
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Immunofluorescence
Frozen tissue slides (human tonsils and skin) were stained 
with rat anti-human TSLP (clone 12F3; gift from L. Bover, 
MD Anderson Cancer Center, Houston, Texas), goat anti–
human CXCL13 (R&D Systems), followed by incubation 
with fluorescence-conjugated secondary antibodies. Slides 
were stained with DAPI, mounted with Vectashield (Vector) 
and acquired using an Eclipse microscope (Nikon).
cell purification from human skin
Fresh AD lesional skin biopsies were washed in PBS, minced 
with a scalpel, and placed in culture at 37°C with 5% CO2 
in RPMI 1640 complemented with 2 mmol/liter glutamine, 
1 mmol/liter sodium pyruvate, 1% nonessential amino acids, 
0.05 mmol/liter 2-mercaptoethanol, 100 U/ml penicillin, and 
100 µg/ml streptomycin (Lonza) with 5% autologous plasma 
and 60 U/ml recombinant human IL-2 (Novartis) to obtain 
enriched skin T cells. Medium was replaced every third day, 
and after 8 to 10 d, T cells that emigrated from tissue samples 
were collected and placed in starvation with low IL-2 before 
phenotypic characterization.
Statistical analysis
Statistical analysis was performed using the Prism soft-
ware v7 (GraphPad). Paired Wilcoxon or t test were 
applied as detailed to compare two groups. Mann-Whit-
ney test was used for nonpaired analysis. Significance 
was retained for P < 0.05.
qPCR data were normalized and center reduced 
using Box-Cox transformation, and plotted using heat map 
package in the R software.
online supplemental material
Fig. S1 shows that human naive CD4 T cells do not express 
TSL PR and do not respond to TSLP stimulation by express-
ing IL-21. Fig. S2 details the expression of Tfh and Th markers 
shown in Fig. 4. Fig. S3 displays the expression of CXCL13 
and CXCR5 in AD and healthy donor skin samples, by IHC 
and FACS staining, respectively.
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